Natural History and Predictors of Progression in Gastric Intestinal Metaplasia: An Australian Longitudinal Cohort Study

GOAL: To characterize the burden and progression of gastric intestinal metaplasia (GIM) in the Australian context. BACKGROUND: Gastric cancer (GC) is uncommon in developed countries such as Australia, but is often diagnosed at a late stage, conferring poor prognosis. GIM is a premalignant lesion that can identify patients for endoscopic surveillance, but only a small number progress to dysplasia or GC. Longitudinal data regarding burden and progression of GIM in the Australian setting are lacking. STUDY: Patients undergoing oesophagogastroduodenoscopy (OGD) between January 2010 and April 2023 were retrospectively reviewed to determine the rates of GIM and GC. Among patients with GIM, a detailed file review assessed risk factors associated with progression to dysplasia or cancer, with analysis using delayed-entry survival analysis. The cohort was linked to the state-wide cancer registry. RESULTS: Of 13,987 individuals undergoing OGD, 1320 (9.4%) had histologically confirmed GIM. GIM patients were older (mean: 64.6 vs. 54.0), and more often born outside Australia (64.5% vs. 41.0%), most frequently from Southern Europe, Eastern Europe, or Eastern Asia. GIM was associated with higher progression rates (7.2% vs. 0.5%). To examine the natural history of GIM, 1217 individuals were included in delayed-entry Cox regression (19 progressors and 1198 nonprogressors). In multivariable analysis, family history of GC (HR=4.9) and extensive GIM (HR=8.0) were independently associated with progression. CONCLUSIONS: GIM is frequently diagnosed on endoscopic biopsy in Australia, particularly among migrant groups. It is associated with higher rates of GC. Extensive disease or a family history is the strongest predictor of progression, regardless of country of origin.

Authors

Institutions

Publication Details

Journal
Journal of Clinical Gastroenterology
Published
2026-11-12
DOI
https://doi.org/10.1097/mcg.0000000000002467
Primary Topic
Gastric Cancer Management and Outcomes
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Natural History and Predictors of Progression in Gastric Intestinal Metaplasia: An Australian Longitudinal Cohort Study

Alan Pham, Douglas Tjandra, Ammar Majeed, Harindra Jayasekara et al.
Journal of Clinical Gastroenterology
Gastric Cancer Management and Outcomes
article

Natural History and Predictors of Progression in Gastric Intestinal Metaplasia: An Australian Longitudinal Cohort Study

Alan Pham, Douglas Tjandra, Ammar Majeed, Harindra Jayasekara, Matthew Morton, Rita A. Busuttil, Jadon Karp, Alex Boussioutas, David Liu
article en

Abstract

GOAL: To characterize the burden and progression of gastric intestinal metaplasia (GIM) in the Australian context. BACKGROUND: Gastric cancer (GC) is uncommon in developed countries such as Australia, but is often diagnosed at a late stage, conferring poor prognosis. GIM is a premalignant lesion that can identify patients for endoscopic surveillance, but only a small number progress to dysplasia or GC. Longitudinal data regarding burden and progression of GIM in the Australian setting are lacking. STUDY: Patients undergoing oesophagogastroduodenoscopy (OGD) between January 2010 and April 2023 were retrospectively reviewed to determine the rates of GIM and GC. Among patients with GIM, a detailed file review assessed risk factors associated with progression to dysplasia or cancer, with analysis using delayed-entry survival analysis. The cohort was linked to the state-wide cancer registry. RESULTS: Of 13,987 individuals undergoing OGD, 1320 (9.4%) had histologically confirmed GIM. GIM patients were older (mean: 64.6 vs. 54.0), and more often born outside Australia (64.5% vs. 41.0%), most frequently from Southern Europe, Eastern Europe, or Eastern Asia. GIM was associated with higher progression rates (7.2% vs. 0.5%). To examine the natural history of GIM, 1217 individuals were included in delayed-entry Cox regression (19 progressors and 1198 nonprogressors). In multivariable analysis, family history of GC (HR=4.9) and extensive GIM (HR=8.0) were independently associated with progression. CONCLUSIONS: GIM is frequently diagnosed on endoscopic biopsy in Australia, particularly among migrant groups. It is associated with higher rates of GC. Extensive disease or a family history is the strongest predictor of progression, regardless of country of origin.

Journal of Clinical Gastroenterology
The University of Melbourne (AU), Cancer Council Victoria (AU), The Alfred Hospital (AU), Melbourne Health (AU), Alfred Health (AU), Monash University (AU)
Good health and well-being
Gastric Cancer Management and Outcomes
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon